Table 2. Correlation of protein expressions of p57Kip2 and CyclinD1 with clinicopathological features of GCA.
| Clinicopathological features | CyclinD1 positive (%) | CyclinD1 negative (%) | P | p57Kip2 negative (%) | p57Kip2 positive (%) | P |
|---|---|---|---|---|---|---|
| Age (year) | 0.773 | 0.637 | ||||
| < 60 | 2(40.0) | 9(33.3) | 10(38.5) | 1(16.7) | ||
| ≥ 60 | 3(60.0) | 18(66.7) | 16(61.5) | 5(83.3) | ||
| Male/female | 0.292 | 0.345 | ||||
| Male | 4(80.0) | 26(96.3) | 25(96.2) | 5(83.3) | ||
| Female | 1(20) | 1(3.7) | 1(3.8) | 1(16.7) | ||
| The stomach diseases | 0.053 | 0.370 | ||||
| No | 4(80.0) | 8(29.6) | 11(42.3) | 1(16.7) | ||
| Yes | 1(20.0) | 19(70.4) | 15(11.5) | 5(11.5) | ||
| Family history of cancer | 0.645 | 0.185 | ||||
| No | 3(60.0) | 16(44.4) | 14(53.8) | 5(83.3) | ||
| Yes | 2(40.0) | 11(55.6) | 12(46.2) | 1(16.7) | ||
| Pathological grade differentiated | 1.000 | 0.012 | ||||
| Middle-low differentiated | 1(20.0) | 6(22.2) | 3(11.5) | 4(66.7) | ||
| High-middle differentiated | 4(80.0) | 21(77.8) | 23(88.5) | 2(33.3) | ||
| Clinical stage | 0.015 | 0.637 | ||||
| < IIIb | 5v100) | 10(37.0) | 10(38.5) | 1(16.7) | ||
| ≥ IIIb | 0(0) | 17(63.0) | 16(61.5) | 5(83.3) | ||
| Lymph node metastasis | 0.578 | 0.117 | ||||
| Negative | 2(40.0) | 6(22.2) | 8(30.8) | 0(0) | ||
| Positive | 3(60.0) | 21(80.0) | 18(69.2) | 6(100) |